Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Tumor Biomarker Blood Testing for Surveillance - Cohort 2: Jan-Dec 2015 New Measure!

The American Society of Clinical Oncology Choosing Wisely® list recommends against performing tumor biomarker blood tests (CA 15-3, CA 27.29, CEA) for breast cancer surveillance in asymptomatic women who have been treated with curative inten...


Reporting Period:

Sort By Rank | Sort By Name  

Note: Results presented here are part of a federal grant from the National Cancer Institute (NCI) awarded to investigators at the Medical College of Wisconsin. The organizations participating in this project agreed to do so on a voluntary basis, and represent a majority of the WCHQ membership eligible for the study.